These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19468984)

  • 1. Defining targets in myeloproliferative disorders: reflecting on what is important.
    Griesshammer M
    Hematol Oncol; 2009 Jun; 27 Suppl 1():2-4. PubMed ID: 19468984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Essential thrombocythemia, polycythemia vera, and myelofibrosis: current management and the prospect of targeted therapy.
    Tefferi A
    Am J Hematol; 2008 Jun; 83(6):491-7. PubMed ID: 18429051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of risk factors: the rationale of the guidelines of the Czech Hematological Society for diagnosis and treatment of chronic myeloproliferative disorders with thrombocythemia.
    Schwarz J; Pytlík R; Doubek M; Brychtová Y; Dulícek P; Campr V; Kren L; Penka M
    Semin Thromb Hemost; 2006 Apr; 32(3):231-45. PubMed ID: 16673277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 2008 World Health Organization classification system for myeloproliferative neoplasms: order out of chaos.
    Tefferi A; Thiele J; Vardiman JW
    Cancer; 2009 Sep; 115(17):3842-7. PubMed ID: 19472396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms.
    Tefferi A; Vardiman JW
    Leukemia; 2008 Jan; 22(1):14-22. PubMed ID: 17882280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow histopathology in myeloproliferative disorders--current diagnostic approach.
    Thiele J; Kvasnicka HM; Orazi A
    Semin Hematol; 2005 Oct; 42(4):184-95. PubMed ID: 16210032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The myeloproliferative neoplasms: insights into molecular pathogenesis and changes in WHO classification and criteria for diagnosis.
    Anastasi J
    Hematol Oncol Clin North Am; 2009 Aug; 23(4):693-708. PubMed ID: 19577165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Essential thrombocythemia in patients with platelet counts below 600x10(9)/L: applicability of the 2008 World Health Organization diagnostic criteria revision proposal.
    Kwon M; Osorio S; Muñoz C; Sánchez JM; Buno I; Díez-Martín JL
    Am J Hematol; 2009 Jul; 84(7):452-4. PubMed ID: 19484738
    [No Abstract]   [Full Text] [Related]  

  • 9. [Diagnosis and treatment of primary thrombocythemia].
    Kiladjian JJ
    Rev Prat; 2005 Oct; 55(15):1671-9. PubMed ID: 16334204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Essential thrombocythaemia.
    Harrison CN; Green AR
    Best Pract Res Clin Haematol; 2006; 19(3):439-53. PubMed ID: 16781482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myelofibrosis--what's in a name? Consensus on definition and EUMNET grading.
    Thiele J; Kvasnicka HM
    Pathobiology; 2007; 74(2):89-96. PubMed ID: 17587880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Essential thrombocythemia in a child: diagnostic and therapeutic dilemma.
    Asghar R; Behzad E; Mohammad GA
    Saudi Med J; 2005 Nov; 26(11):1806-8. PubMed ID: 16311671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New perspectives in managing myeloproliferative disorders: focus on the patient.
    Birgegård G
    Hematol Oncol; 2009 Jun; 27 Suppl 1():5-7. PubMed ID: 19468983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical aspects of myeloproliferative disorders excluding CML].
    Komatsu N
    Rinsho Ketsueki; 2008 Oct; 49(10):1411-9. PubMed ID: 18833926
    [No Abstract]   [Full Text] [Related]  

  • 15. Essential thrombocythemia.
    Finazzi G; Harrison C
    Semin Hematol; 2005 Oct; 42(4):230-8. PubMed ID: 16210036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Published guidelines versus real-life practice in the diagnosis and treatment of essential thrombocythemia.
    Peterson EA; Zypchen L; Lee VH; Nitta J; Foltz LM
    Am J Hematol; 2011 Sep; 86(9):792-4. PubMed ID: 21805495
    [No Abstract]   [Full Text] [Related]  

  • 17. The diagnosis and management of polycythemia vera, essential thrombocythemia, and primary myelofibrosis in the JAK2 V617F era.
    Zhan H; Spivak JL
    Clin Adv Hematol Oncol; 2009 May; 7(5):334-42. PubMed ID: 19521323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is refractory anaemia with ring sideroblasts and thrombocytosis (RARS-T) a necessary or useful diagnostic category?
    Wardrop D; Steensma DP
    Br J Haematol; 2009 Mar; 144(6):809-17. PubMed ID: 19120370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Essential thrombocythaemia: challenges and evidence-based management.
    Harrison CN
    Br J Haematol; 2005 Jul; 130(2):153-65. PubMed ID: 16029444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guideline for investigation and management of adults and children presenting with a thrombocytosis.
    Harrison CN; Bareford D; Butt N; Campbell P; Conneally E; Drummond M; Erber W; Everington T; Green AR; Hall GW; Hunt BJ; Ludlam CA; Murrin R; Nelson-Piercy C; Radia DH; Reilly JT; Van der Walt J; Wilkins B; McMullin MF;
    Br J Haematol; 2010 May; 149(3):352-75. PubMed ID: 20331456
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.